|
Paclitaxel for Injection Clinical Trials
3 actively recruiting trials
Also known as: Tesu
Pipeline
Phase 3: 1Phase 1/2: 1Phase 2/3: 1
Top Sponsors
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.1
- Shanghai Hengrui Pharmaceutical Co., Ltd.1
- Bio-Thera Solutions1
Indications
- Cancer3
- PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer1
- Solid Tumor1
- Cervical Cancer1
- Breast Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.